Transforming cancer care: redefining cancer characterisation and predisposition insight with nanopore sequencing
Webinar Overview
In this webinar, Mathilde Filser highlights the game-changing potential for nanopore sequencing to transform molecular analysis in the field of cancer care.
Mathilde describes how her team at Institut Curie in Paris applied nanopore sequencing to detect cancer predisposition genes, as well as profiling structural variants, methylation and copy number variations in cancer patients.
You will learn:
How nanopore sequencing enables simultaneous detection of fusions, methylation, and copy number profiles in paediatric brain tumours and sarcomas.
How nanopore whole genome sequencing can be used to classify medulloblastomas based on methylation profile.
How nanopore technology offers a solution for identifying structural variants faster and more cost-effectively than conventional molecular techniques.
